Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

(1,743) (729)

Prepaid commodity purchase contracts (184) (88)

Secured advances to suppliers 207 256

Trade accounts payable 1,231 365

Unrealized net gain on derivative contracts (530) (184)

Margin deposits (175) (85)

Other - net 99 (320)

Cash used for operating activities (388) (289)

INVESTING ACTIVITIES

Payments made for capital expenditures (667) (503)

Investments in affiliates (39) (91)

Acquisitions of businesses (net of cash acquired)

and intangible assets (223) (74)

Proceeds from disposal of property, plant

and equipment 55 49

Related party loans (22) (21)

Return of capital from affiliate - 18

Proceeds from sale of investments 23 11

Cash used for investing activities (873) (611)

FINANCING ACTIVITIES

Net change in short-term debt 95 11

Proceeds from long-term debt 2,086 488

Repayments of long-term debt (1,203) (200)

Proceeds from sale of preference shares 845 677

Proceeds from sale of common shares 32 16

Dividends paid to preference shareholders (34) -

Dividends paid to common shareholders (80) (74)

Dividends paid to minority interest
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... have discovered a new explanation for differences in the severity ... a certain gene, the more serious the handicap. The genetic ... that it is the amount of copies of the GDI1 ... the American Journal of Human Genetics , and are ... connected to VIB, a life sciences research institute in Flanders, ...
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
(Date:12/11/2009)... 11 Marrone Bio Innovations (MBI) today ... team. Mr. Chris Hildreth joined MBI as Senior ... for expanding all commercial aspects of the company, ... Kin Sing (Ray) Lam joined MBI as Vice ... development efforts in scaling its broad pipeline of ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... the world join forces in the Global Fight Against Malaria. ... parasite Plasmodium falciparum, which is responsible for the most virulent ... same genus which, despite producing a milder form of malaria, ... vivax , to which is attributed almost 300 million cases ...
... years, the design and manufacturing of circuits at nanoscopic ... frontier fields in new material science and technology. The ... by new discoveries in how they behave precisely when ... new physics at nanoscopic scale at the same time ...
... Biosciences,Corporation (Nasdaq: MATK ) announced today that ... Healthy Living Conference being held on,October 15, 2008 ... Buzy, CFO and,David Abramson, President, will be presenting ... A live audio webcast of Martek,s presentation ...
Other Biology Technology:The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria 2The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria 3A new material could act as a nanofridge for microchips 2
(Date:12/11/2009)... profits have traditionally been limited by the ... seasons can be short. Thanks to researchers ... being introduced that offer growers the ability ... economic bonuses for both producers and consumers. ... blackberry called "primocane-fruiting", which bear fruit on ...
(Date:12/11/2009)... knowledge that smoking is a health risk but why ... adults? In an evaluation for Faculty of 1000 Biology, ... to substance abuse. , Grunberg describes the study, published ... as "fascinating" and suggests it "may have implications to ... abuse". , Nicotine increases the level of dopamine in ...
(Date:12/11/2009)... salmon is the best dietary source of Omega 3, according ... of Almera (UAL). The scientists analysed the eggs, or roe, ... high levels of these fatty acids, which are essential to ... precise understanding of the nutritional potential of the roe of ... has now shown that this is one of the best ...
Breaking Biology News(10 mins):New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Obama Care Parody Takes Look Inside Realities of Universal Health Care Plan 57612 1Obama Care Parody Takes Look Inside Realities of Universal Health Care Plan 57612 2LYSOL 28R 29 Launches Healthier Habits Rewards Program at Schools Nationwide to Help Protect Families from Germs Such as H1N1 57607 1LYSOL 28R 29 Launches Healthier Habits Rewards Program at Schools Nationwide to Help Protect Families from Germs Such as H1N1 57607 2AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 1AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 2
... bird flu that will not suffer from the same kind ... within the next three years, thanks to a new research ... (UK) and Dr Jennifer McKimm-Breschkin from CSIRO (Australia) have been ... develop a new class of inhibitor they have discovered into ...
... Duke University Medical Center researchers has discovered two proteins in ... are responsible for detecting sour tastes. , While the scientific ... and sweet, is known, this is the first study to ... Hiroaki Matsunami, Ph.D., an assistant professor of molecular genetics and ...
... The U.S. Agriculture Department's mad cow disease-testing program ... let processors do their own testing further undercuts ... Illinois scholar writes. , Eating meat from cattle ... disease, can cause Creutzfeldt-Jakob disease, a fatal human ...
Other Biology News:New bird flu drug promises to beat the problem of resistance 2New bird flu drug promises to beat the problem of resistance 3Scientists solve sour taste proteins 2Scientists solve sour taste proteins 3Federal testing for mad cow disease a failure, law review editor says 2Federal testing for mad cow disease a failure, law review editor says 3Federal testing for mad cow disease a failure, law review editor says 4
Apoptosis Detection Systems and Reagents...
Barcoded Slides, 5 Packs of 5 Slides (25/Case)...
Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
...
Biology Products: